Carotid Artery Atherosclerosis Among 65-year-old Swedish Men – A Population-based Screening Study  by Högberg, D. et al.
Carotid Artery Atherosclerosis Among 65-year-old Swedish
Men e A Population-based Screening Study
D. Högberg a,b, B. Kragsterman a, M. Björck a, J. Tjärnström a,b, A. Wanhainen a,*
a Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden
b Department of Surgery, NU-Hospital Organization, Trollhättan, Sweden* Co
Depart
Swede
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
Several studies have shown a beneﬁt from risk factor adjustment and secondary preventive medical treatment
in patients with atherosclerotic manifestations. The present report offers contemporary prevalence data for
carotid atherosclerotic plaque and stenosis in a general population, and the proportion currently receiving
preventive treatment.Objective: There are limited contemporary epidemiological data on the prevalence of carotid atherosclerosis in
the general population. The aim was to determine the prevalence of and risk factors associated with carotid
artery atherosclerosis among 65-year-old men.
Methods: This was a population-based screening study. All 65-year-old men in the County of Uppsala, Sweden,
who attended screening for abdominal aortic aneurysm (AAA) 2007e2009, were invited for duplex scanning of
the carotid arteries.
Results: Of 4801 men invited, 4657 (97%) accepted. Carotid plaques (>2  6 mm) were observed in 1169 (25%)
men, 94 (2.0%) had carotid stenoses (50e99%), and 15 (0.3%) had occluded carotid arteries. In a multivariate
logistic regression model, smoking (OR 1.7, 95% CI 1.5e1.9), hypertension (1.5, 95% CI 1.3e1.7), diabetes
mellitus (1.2, 95% CI 1.0e1.5), and coronary artery disease (1.5, 95% CI 1.3e1.8) were associated with
prevalence of carotid atherosclerosis (plaque and/or stenosis). The use of antiplatelet agents and statins in
participants with a carotid plaque was 20% and 29%, respectively. The corresponding ﬁgures in participants with
a stenosis were 42% and 41%.
Conclusions: This study offers contemporary data on the prevalence of carotid atherosclerosis in a population-
based cohort of 65-year-old men. Most of those at risk had no other clinical manifestation of atherosclerosis, and
therefore had no secondary prevention.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Ischaemic stroke is the most common cause of handicap in
adults and the third most common cause of death in
Sweden. Large-artery atherosclerotic disease accounts for
20% of ischaemic strokes and is the most common cause in
middle-aged patients.1
Screening for carotid stenosis has been highly debated
during the last decade. Although vascular guidelines do not
recommend screening in the unselected general popula-
tion,2e4 there are recommendations for screening of high-
risk adults with cardiovascular risk factors.5,6rresponding author. A. Wanhainen, Institution of Surgical Sciences,
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//dx.doi.org/10.1016/j.ejvs.2014.02.004The main obstacle to screening is identifying a high-risk
population that would beneﬁt from surgical intervention,
but as more studies point to the beneﬁt from risk factor
adjustment such as cessation of smoking and above all best
medical treatment, screening might be indicated in a larger
group. Although selective groups with carotid stenosis may
beneﬁt from surgical intervention, the main reason for
screening is to identify individuals at risk for cardiovascular
events and initiate appropriate treatment.
Well-known risk factors for carotid atherosclerotic dis-
ease are smoking, older age, male sex, hypertension,
hypercholesterolaemia, coronary artery disease, and dia-
betes.7 Multiple risk factors increase the likelihood of ca-
rotid disease, but the cumulative effect of multiple risk
factors has been addressed only in small population
studies.8,9 There are limited epidemiological data on the
prevalence of the disease in the general population, with
most studies being outdated or utilizing various deﬁnitions
and exclusion criteria.10e14
Table 1. Prevalences of carotid artery plaque, stenosis, and
occlusion on duplex and history of carotid endarterectomy in the
population attending screening.
6 D. Högberg et al.The aim was to study the prevalence of, and risk factors
associated with, carotid artery disease in a general popu-
lation of 65-year-old Swedish men.N % (95% CI)
Without plaque or stenosis 3488 74.9
With plaque 1169 25.1 (24.0e26.3)
Unilateral 754 16.2
Bilateral 415 8.9
With stenosis 94 2.0 (1.6e2.4)
Screening detected 81 1.8
History of carotid endarterectomy 13 0.2
Unilateral 80 1.7
Bilateral 14 0.3
50e79%a 63 1.4
80e99%b 31 0.7
With occlusion 16 0.3
Unilateral 15 0.3
Bilateral 1 0.02
With contralateral stenosis 3 0.06
With contralateral plaque 5 0.1
a 50e79% PSV 1.1–2.0 angle 49 and 1.3–3.1 angle 50.
b 80e99% PSV 2.1 angle 49 and 3.2 angle 50.METHODS
In 2006 a general abdominal aortic aneurysm (AAA)
screening programme was launched in the County of
Uppsala in middle Sweden, in which all 65-year-old men,
consecutively identiﬁed through the National Population
Registry, were invited to a one-time ultrasound examination
of the abdominal aorta.15,16
Between 2007 and 2009 all men attending the AAA
screening programme were offered an additional duplex
ultrasound examination of the internal carotid artery (ICA)
free of charge. The examination was carried out simulta-
neously with the AAA screening by an experienced ultra-
sound technician, with a Sequoia (Acuson, Mountain View,
CA, USA), equipped with a 6e8 MHz linear array transducer
(94L). A carotid plaque was deﬁned as a focal intimal-media
thickening (IMT) of 2 mm, over at least 6 mm of length.
The basis for this deﬁnition was a previous plaque-imaging
study where 2  6 mm was considered the threshold for a
meaningful morphological-analysis by means of MRI. Ca-
rotid stenosis was classiﬁed according to the following
Jogestrand criteria (ECST): a peak systolic velocity (PSV) of
1.1e2.0 m/s with Doppler angles between 0 and 49, or a
PSV value of 1.3e3.1 m/s with angles between 50 and 62
equates to a 50e79% stenosis. A PSV value 2.1 m/s with
angles 0e49 and PSV value 3.2 m/s with angles 50e62
equates to an 80e99% stenosis.17,18
All invited individuals who had been operated on with
carotid endarterectomy (CEA) during the 10 years prior to
this investigation were identiﬁed in the Swedish Vascular
registry (Swedvasc) and were included in the stenosis
group, irrespective of the results from the present ultra-
sound screening.
All participants were asked to complete a health ques-
tionnaire on smoking habits and medical history. Coronary
artery disease (CAD) was deﬁned as a history of angina
pectoris or myocardial infarction, cerebrovascular disease
(CVD) as a history of stroke or transient ischaemic attack
(TIA), hypertension as history of hypertension or current
antihypertensive medication, diabetes mellitus as a history
of diet or medically treated diabetes, chronic obstructive
pulmonary disease (COPD) as history of diagnosed COPD,
and claudication as history of symptoms of claudication (i.e.
Rutherford stage 1e3). Former smokers were individuals
who had been smoking during some period of their lives.
Current usage of statins and antiplatelet agents were
recorded according to the WHO Anatomic Therapeutic
Chemical classiﬁcation system (ATC-code) C10A A (HMG-
CoA reductase inhibitors) and B01AC (platelet aggregation
inhibitors).
Statistical evaluation of the data was carried out with
computer software package (SPSS PC version 20.0, SPSS,
Chicago, IL, USA). Proportions are presented with 95%
conﬁdence intervals (95% CI). For comparison of twoproportions, an uncorrected chi-square test was used. To
estimate the odds ratio for factors associated with ICA
atherosclerosis, all variables with p <.1 in the univariate
analyses (Pearson chi-square test) were explored in a
multivariate logistic regression model. The different smoke-
variables were entered separately into the multivariate
analyses. Linear by linear association, a test for trends in a
larger-than-2  2 table using the chi-square distribution,
was used to test the association between risk factors and
the severity of ICA atherosclerosis. As a result of an un-
certain aetiology, participants with an isolated occlusion
were excluded from the risk factor analysis. A p value <.05
was considered signiﬁcant.
The study was approved by the ethics committee of the
Uppsala Region. All participants gave informed consent
prior to the investigation.RESULTS
Of 5936 65-year-old men invited for AAA screening, 4801
(81%) attended, of whom 97% accepted an additional
duplex ultrasound examination of the ICAs. Thus, a total of
4657 participants (9314 carotid arteries) were examined. Of
these, 3488 (75%) participants and 7730 (83%) carotid ar-
teries were normal. An ICA plaque was detected in 1169
(25%) participants in 1584 (17%) carotid arteries. An ICA
stenosis of 50e99% was observed in 94 (2.0%) participants,
in 107 (1.2%) carotid arteries. Sixteen participants (0.3%)
had occluded arteries (Table 1).
Smoking, hypertension, and CAD were independently
associated with carotid atherosclerosis. There were trends
for diabetes mellitus (p ¼ .052) and chronic obstructive
pulmonary disease (p ¼ .081) to be associated with carotid
atherosclerosis, in multivariate analysis. Risk factors are
displayed in Tables 2e4. Separate analysis regarding risk
factor proﬁles showed higher prevalence of antiplatelet use
Table 2. Factors associated with internal carotid artery atherosclerosis.
Factor Atherosclerosis Statistical analysis
Univariate Multivariate
No
N ¼ 3488
% (95% CI)
Yes
N ¼ 1169
% (95% CI)
p OR
(95% CI)
p
Smoking
Never 40 (38e42) 27 (24e30) <.001 0.6 (0.5e0.7) <.001
Ever 60 (59e62) 73 (71e76) <.001 1.7 (1.5e1.9) <.001
Former 49 (48e51) 54 (51e57) .004 1.5 (1.3e1.8) <.001
Current 11 (10e12) 19 (17e21) <.001 1.9 (1.6e2.3) <.001
Hypertension 41 (39e42) 56 (53e59) <.001 1.5 (1.3e1.7) <.001
CAD 8 (8e9) 16 (14e18) <.001 1.5 (1.3e1.8) <.001
Hypercholesterolaemia 27 (26e29) 37 (34e40) <.001 1.1 (0.9e1.3) .279
Claudication 1 (0e2) 2 (1e2) .014 1.4 (0.8e2.6) .178
COPD 7 (6e7) 9 (7e10) .037 1.2 (1.0e1.6) .087
Diabetes mellitus 10 (9e11) 16 (14e18) <.001 1.2 (1.0e1.5) .048
TIA/stroke 4 (3e4) 5 (4e6) .04 1.1 (0.8e1.5) .651
BMI 30 19 (18e21) 21 (18e23) .40 e e
The different smoking variables were entered separately into the model. The baseline analysis was based on “ever smokers”.
CAD ¼ coronary artery disease; COPD ¼ chronic obstructive pulmonary disease; TIA ¼ transitory ischaemic attack; BMI ¼ body mass
index.
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Fig. 1 shows the prevalence of ICA atherosclerosis ac-
cording to severity of disease and smoking habits. Among
individuals with a history of CVD, 59 (31.6%) had uni- or
bilateral ICA plaque, 10 (5.3%) a stenosis, and ﬁve (2.6%) an
occlusion of the ICA.
The prevalence of plaque and stenosis varied between
22% and 47% and 1.5% and 6.7%, respectively among
subgroups with one or multiple major risk factors (Fig. 2).
The prevalence of >50% stenosis among participants with
manifestations of atherosclerosis (i.e. history of coronary
heart disease, cerebrovascular disease, or claudication) was
5.4%, among participants with 3 risk factors (i.e. smoking,
hypertension, diabetes, hyperlipidaemia, BMI >30) 3.8%,
among participants with <3 risk factors 1.8%, and among
participants without reported risk factors 0.5%.Table 3. Factors associated with extent of atherosclerosis.
Factor Normala arteries
% (95% CI)
Uni
Smoking
Never 40 (38e42) 30
Ever 60 (59e62) 70
Former 48 (48e51) 54
Current 11 (10e12) 17
Hypertension 41 (39e42) 52
CAD 8 (8e9) 14
Hypercholesterolaemia 27 (26e29) 34
Claudication 1 (0e2) 1
COPD 7 (6e7) 9
Diabetes mellitus 10 (9e11) 13
TIA/stroke 4 (3e4) 4
BMI 30 19 (18e21) 18
The association between risk factors and the extent of atherosclerosis
disease; COPD ¼ chronic obstructive pulmonary disease; TIA ¼ transi
a Percentages are given within each group of extent of atherosclerosisFour-hundred and forty-two (13%) of those without ICA
atherosclerosis, and 257 (22%) with ICA atherosclerosis
were taking antiplatelet agents, 95.5% ASA and 4.5% clo-
pidogrel. The corresponding numbers of participants
treated with statins were 694 (20%) and 337 (29%),
respectively. The use of antiplatelet agents and statins was
even higher in participants with >50% stenosis, 40 (42%)
and 39 (41%), respectively (Fig. 3). Among 1035 participants
with clinical manifestations of atherosclerosis and/or 3
risk factors, a total of 50 participants with >50% ICA ste-
nosis was found, of whom 35 (70%) had antiplatelet therapy
and 33 (66%) statin treatment. Among 3622 participants
without clinical manifestation of atherosclerosis and <3 risk
factors, a total of 44 participants with >50% ICA stenosis
was found, of whom ﬁve (11%) had antiplatelet therapy and
seven (16%) statin treatment. When the 13 patients with a
history of CEA were excluded, a high usage of antiplateletlaterala disease Bilaterala disease p
(26e33) 22 (18e26) <.001
(67e74) 78 (74e82) <.001
(50e57) 55 (50e60) <.001
(14e20) 23 (19e27) <.001
(49e56) 62 (58e67) <.001
(11e16) 21 (17e24) <.001
(31e38) 41 (36e46) <.001
(0e1) 4 (2e6) .007
(7e11) 9 (6e11) .019
(11e15) 21 (17e25) <.001
(3e6) 6 (4e8) .043
(16e21) 25 (20e29) .23
was tested by linear by linear association. CAD ¼ coronary artery
tory ischaemic attack; BMI ¼ body mass index.
.
Table 4. Factors associated with the severity of atherosclerosis.
Factor Without plaque
% (95% CI)
With plaque With stenosis Univariate p value
Smoking
Never 40 (38e42) 27 (24e30) 17 (9e25) <.001
Ever 60 (59e62) 73 (71e76) 83 (75e91) <.001
Former 49 (48e51) 54 (51e57) 53 (42e63) <.001
Current 11 (10e12) 19 (17e21) 30 (21e40) <.001
Hypertension 41 (39e42) 56 (53e59) 70 (60e79) <.001
CAD 8 (8e9) 16 (14e18) 29 (20e39) <.001
Hypercholesterolemia 27 (26e29) 37 (34e39) 50 (40e60) <.001
Claudication 1 (0e2) 2 (1e2) 7 (1e12) .009
COPD 7 (6e7) 9 (7e10) 7 (1e12) .025
Diabetes mellitus 10 (9e11) 16 (14e18) 21 (12e29) <.001
TIA/stroke 4 (3e4) 4 (3e6) 12 (5e19) .037
BMI 30 19 (18e21) 21 (18e23) 27 (18e36) .29
The association between risk factors and the extent of atherosclerosis was tested by linear by linear association. CAD ¼ coronary artery
disease; COPD ¼ chronic obstructive pulmonary disease; TIA ¼ transitory ischaemic attack; BMI ¼ body mass index.
8 D. Högberg et al.agents and statins remained among those with a screening
detected carotid stenosis, 35% and 38%, respectively.
DISCUSSION
In this large population-based study of 65-year-old men, the
overall prevalence of atherosclerotic lesions was 25% and
that of moderate-severe stenosis 2%. The strongest inde-
pendent risk factor was current smoking. Although the
population-based study design, together with the high
participation rate, makes the results generalizable, there are
methodological limitations.
The reported prevalence of ICA stenosis in the literature
varies between 0 and 22%, with a pooled prevalence esti-
mate of 4.2%.12 Several factors contribute to this variation,
including non-population-based cohorts, different exclusion
criteria (i.e. CVD or diabetes), wide age intervals, lowFigure 1. Prevalence (%) of atherosclerotic plaque/stenosis among
never smokers, former smokers, and current smokers.participation rates and different deﬁnitions of stenosis,
making relevant comparisons difﬁcult. In the Cardiovascular
Health study, an ICA stenosis prevalence of 6.2% was re-
ported among 5116 men aged >65 years.19 However the
study was published in 1992 and may therefore not be
relevant in the contemporary context. In the Tromsø study
from 2001, a prevalence of 3.8% of moderate ICA stenosis
was found among 3016 men aged 24e84 years. However,
only the right carotid artery was examined, creating a sys-
tematic underestimation. True prevalence estimates of
different age and gender speciﬁc groups are difﬁcult to
make from these data.10 Similar to the present ﬁndings,
Ratchford et al.20 reported a prevalence of 2.2% in 2009 and
in a recent meta-analysis the pooled cohort data from four
large population-based studies of clinical asymptomatic
patients with carotid artery stenosis of >50%, demon-
strated a prevalence of 2.3% for men aged 60e69 years.13
The variation in deﬁnition of a carotid artery plaque
makes comparisons of these prevalences even more com-
plex. Furthermore, the studied target vessel varies between
the common carotid artery, the carotid bifurcation, and/or
the ICA. Another important factor to consider is whether
the plaque deﬁnition uses a relative measure (i.e. IMT
>50%) or a ﬁxed measure, as in the present paper. In some
publications, prevalences as high as 59e78% were re-
ported.19,21,22 Mathiesen et al.23 found a 53% prevalence of
plaque (deﬁned as a focal IMT >50%), among 1726 men
with mean age 59.6 years, in 2011. Using the same deﬁni-
tion, Rundek et al.24 in 2008 reported a plaque prevalence
of 58% among 2189 asymptomatic participants (40% men)
of mean age 68 years in the Northern Manhattan study. The
MESA study from 200625 used a standardized self-made
carotid plaque index and reported a prevalence of 45% in
3034 examined men with mean age of 63 years. The deﬁ-
nition used in the present study (IMT >2  6 mm) is
somewhat stricter than previous deﬁnitions and may
contribute to the relatively low (25%) prevalence of plaque.
Smoking was reported to be the strongest independent
risk factor for carotid artery atherosclerosis.25e27 In this
study 73% of individuals with atherosclerotic plaque, and
Figure 2. Prevalence (%) of carotid plaques/stenosis among in-
dividuals with one or more of the four major risk factors (smoking,
coronary artery disease, hypertension, and diabetes).
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smoking. The observed association between smoking and
the degree and distribution of the disease resembles a
doseeresponse relationship, implying a possible causative
effect of smoking. Daily smoking among 65-year-old Swed-
ish men has decreased during the last three decades28 and
the number of current smokers is lower in comparison with
previous reports.10,26 Thus, even if current smoking is theFigure 3. Usage (%) of antiplatelet agents and statins among
participants with or without atherosclerosis.single most important risk factor for carotid artery arterio-
sclerosis, the relatively low proportion of abuse further
explains the lower than expected plaque prevalence in this
population.
Hypertension, diabetes mellitus, and CAD were all
signiﬁcantly and independently associated with athero-
sclerosis in the carotid arteries, in agreement with previ-
ous reports.10,25 Subgroup analysis showed that
individuals with multiple major risk factors have a further
increased risk.
Medical therapy may affect the prevalence of athero-
sclerosis, including carotid disease, in the population. Use
of medication is, however, seldom reported in prevalence
studies.10,24e27 The observed high usage of statins and
antiplatelet agents in the present population, is in
accordance with the reports from Rundek et al.,24 and
may have contributed to the comparatively low preva-
lence of carotid artery lesions. In many countries the use
of statins has increased substantially over recent decades,
and today about 9.5% of all Swedish men are treated.29
The present study revealed that about 40% of those
with a screening detected stenosis were already taking
statins and/or antiplatelet therapy. Thus although the
healthcare system has identiﬁed a substantial proportion
of those potentially beneﬁtting from secondary preven-
tive treatment, there is clearly more to be done. This
study implies that the implemented abdominal aortic
screening programme of 65-year-old men in Sweden, of-
fers an opportunity to ﬁnd individuals with carotid artery
atherosclerosis who may beneﬁt from best medical
treatment. As the majority of participants with carotid
stenosis were not on preventive medical treatment and
current medical practice/preventive guidelines do not
apply to them, further evaluation of such a programme is
warranted.
The risk factor analysis in the present study is limited by
small numbers of individuals reporting some of the risk
factors, making the analysis susceptible to type II statistical
error. This was most apparent for claudication, reported by
only 1% of the participants. Another limitation is the
questionnaire-based design, self-reporting data are prone to
recall bias and those not reporting certain risk factors may
still have them. The strength is the large cohort together
with the population-based study design, and the high
participation rate.Conclusion
This study offers contemporary data on the prevalence of
carotid atherosclerosis in a population-based cohort of 65-
year-old men. The prevalence of atherosclerotic plaques in
the ICAs was 25%, while the prevalence of >50% stenosis
was 2.0%. Smoking, hypertension, diabetes mellitus, and
CAD were independent risk factors and individuals with
several risk factors had a higher prevalence of stenosis.
Most of those at risk had no other clinical manifestation of
atherosclerosis, and were therefore taking no secondary
prevention.
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